• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: AV-TEMECULA-CT MITRACLIP SYSTEM CLIP DELIVERY SYSTEM NT; MITRACLIP DELIVERY SYSTEM

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

AV-TEMECULA-CT MITRACLIP SYSTEM CLIP DELIVERY SYSTEM NT; MITRACLIP DELIVERY SYSTEM Back to Search Results
Catalog Number CDS0501
Device Problem Failure To Adhere Or Bond (1031)
Patient Problems Arrhythmia (1721); Death (1802); Low Blood Pressure/ Hypotension (1914); Mitral Regurgitation (1964); Tissue Damage (2104); Cardiogenic Shock (2262); Respiratory Failure (2484)
Event Date 05/04/2018
Event Type  Death  
Manufacturer Narrative
(b)(4).During processing of this complaint, attempts were made to obtain complete event, patient and device information.The clip remains in the patient.Investigation is not yet complete.A follow up report will be submitted with all additional relevant information.
 
Event Description
This is filed to report tissue damage,worsening mitral regurgitation, cardiogenic shock and death.It was reported that this was a mitraclip procedure to treat a mixed mitral regurgitation (mr) with multiple jets, possible pseudo cleft and grade of 4+.The first clip (70726u277) was implanted at a2/p2.The mr remained at 4+, with a lateral jet remaining.The second clip (70822u160) was placed lateral to a1/p1; however, grasping was difficult due to the leaflet anatomy.The clip was repositioned and multiple grasping attempts were made.It was believed that there was possible tearing of the valve or chordae.The clip was deployed lateral to a2/p2 and the mr was reduced to 3-4.The procedure was discontinued.One day after the procedure, the patient expired due to cardiogenic shock and worsening mr.In the physicians opinion, the procedure was long and possible tearing of valve or cords could have caused or contributed to the patient death.No additional information was provided.
 
Manufacturer Narrative
(b)(4).The device was not returned for analysis.A review of the lot history record identified no manufacturing nonconformities issued to the reported.Additionally, a review of the complaint history identified no similar incidents reported from this lot.All available information was investigated and the reported difficulty grasping appears to be related to patient morphology/pathology (cleft/fold).The reported death was due to the cardiogenic shock, worsening mitral regurgitation (mr), and the long and complex procedure, but not directly related to the device.The worsening mr was due to the procedural conditions of difficulty grasping and possible tearing of the valve /chordae.The reported tissue damage appears to be related to procedural circumstances of the difficult grasping; however, a definitive cause for the cardiogenic shock was undetermined.The reported patient effects of death, worsening mr, tissue damage and cardiogenic shock, as listed in the mitraclip system instructions for use, are known possible complications associated with mitraclip procedures.There is no indication of a product quality issue with respect to manufacture, design or labeling.This event was further reviewed by an abbott vascular medical affairs director.The reviewer concluded that the death was related to the procedure which was long and complex, but not directly related to the device which exhibited no malfunction.
 
Event Description
Subsequent to the previously filed report, the following information pertaining to this event was obtained from article title, percutaneous edge-to-edge mitral valve repair: navigating the challenges of multiple mechanisms for mitral regurgitation.The is a case presentation of an 83-year-old male patient whom underwent a mitraclip procedure to treat mitral regurgitation (mr) with an mr grade of 4.The first clip was implanted, reducing mr to 3-4.A second clip delivery system (cds 70822u160) was advanced.Grasping was difficult due to a pre-existing cleft on the posterior leaflet.The clip was implanted and a large residual jet was seen between the two clips.The patient developed decompensated heart failure, atrial fibrillation requiring electrical cardioversion.The patient was stabilized with medication.A third cds was advanced, but the leaflets could not be grasped, and a chordae flail was noted.The mr returned to 4.The third clip was not implanted and was removed.The patient at this point had worsening hypoxemia and hypotension requiring medication, a balloon pump was placed, the patient went into cardiogenic shock and the patient passed away the following day.No additional information was provided.
 
Manufacturer Narrative
(b)(4).The clip remains in the patient.Investigation is not yet complete.A follow up report will be submitted with all additional relevant information.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
MITRACLIP SYSTEM CLIP DELIVERY SYSTEM NT
Type of Device
MITRACLIP DELIVERY SYSTEM
Manufacturer (Section D)
AV-TEMECULA-CT
abbott vascular
26531 ynez road
temecula CA 92591 4628
MDR Report Key7561418
MDR Text Key109812707
Report Number2024168-2018-04059
Device Sequence Number1
Product Code NKM
Combination Product (y/n)N
PMA/PMN Number
P100009
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type company representative,health
Remedial Action Other
Type of Report Initial,Followup,Followup
Report Date 06/27/2019
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Device Operator Health Professional
Device Expiration Date08/22/2018
Device Catalogue NumberCDS0501
Device Lot Number70822U160
Was Device Available for Evaluation? No
Initial Date Manufacturer Received 05/10/2018
Initial Date FDA Received06/01/2018
Supplement Dates Manufacturer Received08/21/2018
06/03/2019
Supplement Dates FDA Received08/27/2018
06/27/2019
Is This a Reprocessed and Reused Single-Use Device? No
Patient Sequence Number1
Treatment
2 IMPLANTED MITRACLIP; STEERABLE GUIDE CATHETER 1 IMPLANTED MITRACLIP; STEERABLE GUIDE CATHETER ONE (1) IMPLANTED MITRACLIP
Patient Outcome(s) Death;
Patient Age83 YR
-
-